<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03375190</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00081185</org_study_id>
    <nct_id>NCT03375190</nct_id>
  </id_info>
  <brief_title>A Comparison of Peripheral Nerve Catheter Securement Techniques at the Insertion Site in Healthy Volunteers</brief_title>
  <official_title>A Comparison of Peripheral Nerve Catheter Securement Techniques at the Insertion Site in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Continuous peripheral nerve block catheters are used for prolonged analgesia, but are often
      associated with complications such as catheter failure or dislodgement. This is a single
      center, prospective study to compare peripheral nerve catheter securement techniques at the
      insertion site in healthy volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will involve the placement of subcutaneous peripheral nerve catheters in healthy
      volunteers utilizing 6 different securement techniques. The primary outcome is the force
      required to dislodge the peripheral nerve catheter by 1 centimeter as measured by a
      dynamometer in Newtons. The secondary endpoint will be the force required to disrupt the
      catheter dressing.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 15, 2018</start_date>
  <completion_date type="Actual">February 28, 2018</completion_date>
  <primary_completion_date type="Actual">February 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Force required to dislodge catheter by 1 centimeter</measure>
    <time_frame>1 study day</time_frame>
    <description>This force will be measured using a dynamometer in Newtons</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Force required to disrupt catheter dressing</measure>
    <time_frame>1 study day</time_frame>
    <description>This force will be measured using a dynamometer in Newtons</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Regional Anesthesia Morbidity</condition>
  <arm_group>
    <arm_group_label>Dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transparent film dressing (TegadermTM CHG Chlorhexidine Gluconate IV Securement Dressing, 3M Health Care, St. Paul, MN, USA) alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dressing + adhesive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transparent film dressing + topical skin adhesive (SwiftSetTM Topical Skin Adhesive, CovidienTM, Devon, UK) at insertion site</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dressing + adhesive + strips (parallel)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transparent film dressing + topical skin adhesive + reinforced skin closure strips (Steri-StripTM, 3M Health Care, St. Paul, MN, USA) placed parallel to long axis of catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dressing + adhesive + strips (perpend)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transparent film dressing + topical skin adhesive + reinforced skin closure strips (Steri-StripTM, 3M Health Care, St. Paul, MN, USA) placed perpendicular to long axis of catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dressing + adhesive + strips + benzoin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transparent film dressing + topical skin adhesive + skin closure strips + topical benzoin (Compound Tincture of Benzoin USP 10%, Professional Disposables International, Inc., Orangeburg, NY, USA) spread in a 12 centimeter by 14 centimeter area around the insertion site</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dressing + adhesive + strips + spray</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transparent film dressing + topical skin adhesive + skin closure strips + medical adhesive spray (AdaptTM Medical Adhesive, Hollister Incorporated, Libertyville, IL, USA) in a 12 centimeter by 14 centimeter area around the insertion site</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dressing</intervention_name>
    <description>Transparent film dressing (TegadermTM CHG Chlorhexidine Gluconate IV Securement Dressing, 3M Health Care, St. Paul, MN, USA) alone</description>
    <arm_group_label>Dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dressing + adhesive</intervention_name>
    <description>Transparent film dressing + topical skin adhesive (SwiftSetTM Topical Skin Adhesive, CovidienTM Devon, UK) at insertion site</description>
    <arm_group_label>Dressing + adhesive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental: Dressing + adhesive + strips (parallel)</intervention_name>
    <description>Transparent film dressing + topical skin adhesive + reinforced skin closure strips (Steri-StripTM, 3M Health Care, St. Paul, MN, USA) placed parallel to long axis of catheter</description>
    <arm_group_label>Dressing + adhesive + strips (parallel)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental: Dressing + adhesive + strips (perpend)</intervention_name>
    <description>Transparent film dressing + topical skin adhesive + reinforced skin closure strips (Steri-StripTM, 3M Health Care, St. Paul, MN, USA) placed perpendicular to long axis of catheter</description>
    <arm_group_label>Dressing + adhesive + strips (perpend)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental: Dressing + adhesive + strips + benzoin</intervention_name>
    <description>Transparent film dressing + topical skin adhesive + skin closure strips + topical benzoin (Compound Tincture of Benzoin USP 10%, Professional Disposables International, Inc., Orangeburg, NY, USA) spread in a 12 centimeter by 14 centimeter area around the insertion site</description>
    <arm_group_label>Dressing + adhesive + strips + benzoin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental: Dressing + adhesive + strips + spray</intervention_name>
    <description>Transparent film dressing + topical skin adhesive + skin closure strips + medical adhesive spray (AdaptTM Medical Adhesive, Hollister Incorporated, Libertyville, IL, USA) in a 12 centimeter by 14 centimeter area around the insertion site</description>
    <arm_group_label>Dressing + adhesive + strips + spray</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-85 years

          -  American Society of Anesthesiologists Physical Status I-II

          -  BMI 18-30 kg/m2

        Exclusion Criteria:

          -  Inability to cooperate with or understand protocol

          -  Inability to understand or speak English

          -  Allergy to adhesive or tape

          -  Local infection in lower extremities

          -  Neurologic deficit or disorder

          -  Anticoagulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Shaughnessy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke UMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2017</study_first_submitted>
  <study_first_submitted_qc>December 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 15, 2017</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

